IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status.

Autor: Saikumar Jayalatha AK; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pathology and Medical Biology, Groningen, The Netherlands.; Shared first authorship., Ketelaar ME; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pathology and Medical Biology, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, Groningen, The Netherlands.; Shared first authorship., Hesse L; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pathology and Medical Biology, Groningen, The Netherlands.; Shared first authorship., Badi YE; National Heart and Lung Institute, Department of Respiratory Cell and Molecular Biology, Imperial College London, London, UK., Zounemat-Kermani N; National Heart and Lung Institute, Department of Respiratory Cell and Molecular Biology, Imperial College London, London, UK., Brouwer S; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pathology and Medical Biology, Groningen, The Netherlands., Dijk NF; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, Groningen, The Netherlands., van den Berge M; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pulmonary Diseases, Groningen, The Netherlands., Guryev V; University of Groningen, GRIAC Research Institute and European Research Institute for the Biology of Ageing, Groningen, The Netherlands., Sayers I; Centre for Respiratory Research, NIHR Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Vonk JE; University of Groningen, University Medical Center Groningen, GRIAC Research institute, Department of Epidemiology, Groningen, The Netherlands., Adcock IM; National Heart and Lung Institute, Department of Respiratory Cell and Molecular Biology, Imperial College London, London, UK., Koppelman GH; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, Groningen, The Netherlands., Nawijn MC; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Department of Pathology and Medical Biology, Groningen, The Netherlands m.c.nawijn@umcg.nl.

Publikováno v: The European respiratory journal [Eur Respir J] 2024 Jun 20; Vol. 63 (6). Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Long-term outcomes for patients with cystic fibrosis in Australia.

Autor: Gaskin, Kevln J., Wllcken, Bridget

Publikováno v: Medical Journal of Australia; 10/3/2011, Vol. 195 Issue 7, p370-371, 2p